P-580 Impact of third pronucleus size as a predictive marker for genetic outcomes in 349 zygotes with three pronuclei (3PN)
María-José Escribá, J. Teruel(Barcelona IVI Clinic), C Miret, J Crespo, E. De la Fuente(Universidad de Guadalajara), A Alambiaga, Lorena Rodrigo, Carmen Rubio(Igenomix), Daniel González(University of North Carolina at Chapel Hill), Manuel Moya Benavent
Cited by 1
Related Papers
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
|Clinical Therapeutics|2016|170
Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents
|Clinical Microbiology Reviews|2013|147